We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.05 | 2.00 | 2.10 | 2.10 | 2.05 | 2.05 | 690,953 | 14:55:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.39 | 15.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/11/2019 00:30 | Surprised you say that as you were pushing it hard the other day. Just a ramp? They also have a licensing deal due soon. | knowing | |
27/11/2019 16:16 | Knowing, too high risk, more into (FOXT) & (AOR) both breaking out Not long to wait here me thinks either before Xmas or early in 2020, to kick the decade off and running. | ny boy | |
27/11/2019 11:04 | Whilst waiting for this to blossom, maybe in the Spring, will quietly add NFX on the dips | knowing | |
25/11/2019 10:15 | Did say Cambridge Cognitive at 25pCOG. Market cap peanuts should start moving higher. A double I reckon. | montyhedge | |
25/11/2019 08:38 | hahaha, yes exactly the same nobby! "finally an email about a RNS" - "ohhhhh". Urghh. | 2theduke | |
25/11/2019 08:37 | They are just doing a trial run to get everyone ready for the biggie, keeping you on your toes nobby lol Nothing like an early Monday moment of excitement | ny boy | |
25/11/2019 07:52 | It’s a fair point. On the surface it is purely an admin RNS so why is it value enhancing? | rafboy | |
25/11/2019 07:29 | So to extend that thought perhaps it suggests the deal is very close. Plus maybe that the deal is with a big Pharma..... Probably trying to deduce too much as usual....... | nobbygnome | |
25/11/2019 07:15 | Good point. OK maybe fair enough..... | nobbygnome | |
25/11/2019 07:09 | Big pharma may have demanded this prior to deal | drsous | |
25/11/2019 07:07 | I was excited for a moment there when I saw STX had an RNS this morning..... Why on earth do they consider that news to be price sensitive and therefore subject to an RNS. Very strange..... | nobbygnome | |
21/11/2019 22:39 | Small time selling | ny boy | |
21/11/2019 14:40 | I speak from bitter experience although I'm not bitter.....much ! QFI.....what skulduggery...its been a right game. Major shareholders bent as none Bob notesWith blue sky stocks never lose sight of the fundamentals..becaus | kop202 | |
21/11/2019 14:34 | I spoke too soon. It beggars belief that people are selling now, if they have any clue what is going on.... | nobbygnome | |
21/11/2019 14:03 | You could be right kop202 only the rises here have been backed up by news. Look back and see yourself | 78steve | |
21/11/2019 13:19 | A close above 185.5p is interesting A close above 190p opens the way to break to fresh highs | ny boy | |
21/11/2019 11:44 | Its typical AIM. The share price is "made up" by the intermediaryIn the development phase they inflate the share price based on what the company could be potentially. Punters get carried away......Then before the potential is likely to be realised they drop the share price and base it on fundamentals......an | kop202 | |
21/11/2019 11:33 | MMs seem very twitchy this morning.....which is unusual here! | nobbygnome | |
21/11/2019 11:12 | Anyone else remember The Black Prince aka Colin Blackburn, and Shield's glory days, when we made out like bandits? | wantage | |
21/11/2019 11:07 | The madness is that the market cap now is only about £40 million higher (allowing for a small increase in no of shares following a fund raising a few years ago) than after the floatation in 2015. If you think how far the company has progressed Feraccru since then, that statistic is clearly completely and utterly ridiculous. Sometimes you could say it is better to travel in hope than arrive but in this case that is definitely not applicable. The company has delivered several positive trial results including the non inferiority study with the iv treatment, a sales partner in Europe, most importantly approval with a broad label by the FDA and about to deliver licensing deals in the US and China. Madness is the word! | nobbygnome | |
21/11/2019 11:00 | Let’s see if it lasts the day | crankyman | |
21/11/2019 10:33 | A breach of the previous high of 195p would be highly significant because above that is all blue sky (obviously)! | nobbygnome | |
21/11/2019 10:22 | Yes Nobby, possibly a significant moment after a long period of tight consolidation Difficult to keep a major US commercialization deal watertight imo | ny boy | |
21/11/2019 09:51 | Good timing for my buys today and earlier in the week😜. A leak perhaps that a deal is imminent..... It will be interesting to see what happens the rest of today. | nobbygnome | |
21/11/2019 09:32 | Looks like there are stirrings of a rise this morning. Finncap have gone on the bid aggressively which usually presides a rise. Consequently I have picked up a few more via Spreadbet..... | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions